SP

Stefano Portolano

Chief Executive Officer

AZAFAROS B.V.

Basel, Basel-Stadt


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
AZAFAROS B.V.
Industry
research
Employees
22.0
Seniority
C suite
Annual Revenue
1700000.0
Total Funding
27503537.0
Latest Funding
Series A

Technologies

Outlook Apache Mobile Friendly Google Maps Google Tag Manager Google Maps (Non Paid Users) Google Font API WordPress.org AI

Keywords

biotech biotechnology research rare diseases metabolic disorders lysosomal storage disorders nizubaglustat oral small molecule disease-modifying therapy glycosphingolipid metabolism clinical development pharmacodynamics drug development orphan drug designation fda approval patient advocacy therapeutic approach central nervous system clinical trials biopharmaceuticals genetic disorders innovative treatments patient resources healthcare solutions investor relations medical affairs research collaboration patient organizations clinical research safety profile pharmacokinetics disease pathways neurological conditions enzyme replacement therapy access policy expanded access evidence-based medicine scientific publications rare genetic diseases health outcomes biotechnology research & development healthcare innovation therapeutic pipeline patient engagement international regulations collaborative research clinical strategies leadership team capacity building community impact symptom management healthcare access health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans